A Phase 1 Clinical Trial, Open-label, Randomized Study in Healthy Subjects to Evaluate Pharmacokinetic Characteristics and Safety After Oral Administration of NVP-2102 and NVP-2102-R in Healthy Subjects
Latest Information Update: 11 Apr 2022
Price :
$35 *
At a glance
- Drugs NVP 2102 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Navipharm
- 17 Jan 2022 Status changed from active, no longer recruiting to completed.
- 25 Nov 2021 New trial record
- 12 Nov 2021 Status changed from not yet recruiting to active, no longer recruiting.